艾滋病广谱中和抗体专利分析

Patent Analysis on Broadly Neutralizing HIV Antibodies

利用Derwent Innovation平台,以(broadly neutralizing antibod*or broadly-neutralizing antibod*or bNAb*) and (HIV or human immunodeficiency virus or AIDS or acquired immune deficiency syndrome) and vaccin*为检索词,检索条件是在标题或摘要中出现检索词,检索时间截至2018年8月7日,筛选出309件广谱中和抗体的专利申请,同族专利45件。该领域自1993年出现专利申请,2011年达到峰值后呈下降趋势。该领域最重要的目标市场是美国和欧洲。美国的国际艾滋病疫苗行动组织、Scripps研究所、美国国家健康研究院、杜克大学、加州大学Santa Cruz分校、儿童医学中心和纽约大学是领先的研究机构,前3位的发明人分别为杜克大学的Haynes Barton F、国际疫苗行动组织的Phogat Sanjay K和Hoffenberg Simon。该领域已具有一定的技术基础并处于改进中且与治疗有联系。

By using Derwent Innovation as the search tool, and (broadly neutralizing antibod* or broadlyneutralizing antibod* or bNAb*) and (HIV or human immunodeficiency virus or AIDS or acquired immune deficiency syndrome) and vaccin* as the search words, 309 patents were selected and they belong to 45 patent families. The first patent application was in 1993, and it showed a downward trend after reaching its peak in 2011. The most important target markets are the United States and Europe, while the International AIDS Vaccine Initiative, the Scripps Research Institute, US Health, Duke university, university of California(Santa Cruz), Children's Medical Center and New York university are main players. The top three inventors are Haynes Barton F from Duke university, Phogat Sanjay K and Hoffenberg Simon from the International AIDS Vaccine Initiative. The field has a certain technical foundation and is being improved and is related to treat subject.